The price of Sesen Bio Inc. (NASDAQ: SESN) closed at 0.45 in the last session, down -32.74% from day before closing price of $0.67. In other words, the price has decreased by $-0.2191 from its previous closing price. On the day, 12166939 shares were traded. SESN reached its highest trading level at $0.6000 during the session, while it also had its lowest trading level at $0.4010.
We take a closer look at SESN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
On June 11, 2019, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.
As of this moment, Sesen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1.90. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.40 while its Price-to-Book (P/B) ratio in mrq is 0.63.
Stock Price History:
Over the past 52 weeks, SESN has reached a high of $1.47, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is 0.7026, while the 200-Day Moving Average is calculated to be 0.6842.
According to the various share statistics, SESN traded on average about 2.47M shares per day over the past 3-months and 738.62k shares per day over the past 10 days. A total of 199.46M shares are outstanding, with a floating share count of 198.44M. Insiders hold about 0.10% of the company’s shares, while institutions hold 14.50% stake in the company. Shares short for SESN as of Jul 14, 2022 were 3.8M with a Short Ratio of 1.45, compared to 11.71M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.91% and a Short% of Float of 1.91%.
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of $-0.13 for the current quarter, with a high estimate of $-0.13 and a low estimate of $-0.13, while EPS last year was $-0.15. The consensus estimate for the next quarter is $-0.12, with high estimates of $-0.12 and low estimates of $-0.12.
Analysts are recommending an EPS of between $-0.4 and $-0.4 for the fiscal current year, implying an average EPS of $-0.4. EPS for the following year is $-0.35, with 1 analysts recommending between $-0.35 and $-0.35.